Budgeting JournalsBudgeting Journals
Menu
  • Economy
  • Editor’s Pick
  • Investing
  • Latest News
  • Stock
Latest News

The Tomahawk factor: US long-range missiles are the battlefield gamechanger Putin should fear

The U.S. Navy’s Tomahawk cruise missile would put Moscow well within target range if President Donald Trump were to fulfill Ukrainian President…
Latest News

‘Both sides are wrong’: Longtime Obamacare critic says GOP is mistaken in shutdown struggle

In the view of Avik Roy — one of the first and most vocal critics of the Affordable Care Act (ACA), also…
Economy

PayPal stock price forecast ahead of earnings: buy or sell?

PayPal stock remains in a tight range this month as traders waited for the upcoming earnings, which will provide more color on…
Economy

Here’s why the Kering share price is firing on all cylinders

Kering share price has gone parabolic in the past few months, making it one of the best-performing companies in the CAC 40…
Economy

Top S&P 500, VOO, and SPY ETFs news to watch this week

The S&P 500 Index jumped to a record high last week as the earnings season gained steam, and after Donald Trump confirmed…
Economy

Canada’s TSX Index is in a bull run: top catalysts to watch

The TSX Composite Index continued its strong bull run last week despite major headwinds. It rose by 0.55%, even as relations between…
Economy

Top 3 Dow Jones Index and DIA ETF stocks to watch this week

The Dow Jones Index is in a strong bull run this year after soaring by almost 30% from its lowest level this…
Stock

Gold slips 2% as bear takes control amid US-China trade talk; can bulls stage a comeback?

Gold prices have slipped from their record highs as the yellow metal plunged 2% on Monday due to decreasing safe-haven demand.  This…
Stock

Microsoft shares climb as Guggenheim upgrades MSFT to ‘buy’ on AI-led growth

Microsoft shares climbed nearly 1.5% to $531.40 in premarket trading on Monday after Guggenheim upgraded the stock to “buy” from “neutral,” citing…
Stock

Is it too late to buy Avidity stock after Novartis deal?

Novartis (NYSE: NVS) revealed plans of acquiring Avidity Biosciences Inc (NASDAQ: RNA) in a $12 billion all-cash transaction – valuing each share…
Older posts
Newer posts
    • Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.

      By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    • Trending News

      • Stock

        Eli Lilly falls after a 6 month rally; is this a buy the dip opportunity?

      • Economy

        Best crypto to buy as the fear and greed index hits 62

      • Stock

        Tesla stock trades higher on Wednesday: is the options market signaling more upside?

    • Latest News

      • SPYI ETF: Is this 12% yielding JEPI rival a good fund to buy?
      • EU fiscal rules are a security risk, German economy minister says
      • The bullish case for the Circle stock as it remains in a bear market
    • Popular News

      • U.S. stocks rise, oil prices fall after Trump backs off threat to hit Iran’s power grid
      • Judge says he must still approve sale of Infowars to The Onion
      • Palantir joins list of 20 most valuable U.S. companies, with stock more than doubling in 2025
    • About Budgeting Journals

      • Privacy Policy
      • Terms & Conditions

    Copyright © 2026 budgetingjournals.com | All Rights Reserved